Target intelligence / Profile preview

ubiquinol-cytochrome c reductase binding protein pseudogene (null)

Target
null
Molecular classification
Other (Pseudogene)
01

Overview

The "ubiquinol-cytochrome c reductase binding protein pseudogene" is a human pseudogene related to the UQCRB gene, which encodes a subunit of mitochondrial complex III. Unlike functional genes, a pseudogene is a genomic DNA sequence similar to a gene but typically nonfunctional due to mutations or a lack of expression. This means it does not encode a protein and is not part of the mitochondrial respiratory chain[5][8]. No evidence supports its use as a receptor, therapeutic target, or marker for disease or therapy monitoring. The designation is problematic for drug target purposes because: - It is a pseudogene and not a protein or functional RNA product. - Pseudogenes, by definition, do not normally encode functional proteins or possess clear biological functions[5][8]. - The canonical drug target "ubiquinol-cytochrome c reductase binding protein" refers instead to the UQCRB protein, which is encoded by a different, protein-coding gene (ENSG00000156467), not this pseudogene[1][3]. - The gene symbol ENSG00000254373 is clearly marked as a pseudogene (e.g., as UQCRBP1)[7]. - Such pseudogenes are not considered therapeutic targets in pharmacology, biomedicine, or drug discovery[5][8]. If structured information about the canonical therapeutic target is required, the correct entity is "ubiquinol-cytochrome c reductase binding protein" (UQCRB), not this pseudogene. The current entry should not be treated as a valid molecular target for drug discovery, diagnostics, or therapeutic interventions.

Other names
UQCRBPUQCRBP1UQCRB pseudogene

Beyond the preview

Go deeper on ubiquinol-cytochrome c reductase binding protein pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ubiquinol-cytochrome c reductase binding protein pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call